Table 1.
Patient characteristics and treatment details after propensity score matching
Characteristics | ART+IMRT (n = 50) |
IMRT (n = 50) |
P |
---|---|---|---|
Age (years) | 54 (16~72) | 55 (22~73) | 0.865 |
Gender | 0.500 | ||
Male | 33 (66%) | 34 (68%) | |
Female | 17 (34%) | 16 (32%) | |
History of smoking | 0.500 | ||
Yes | 22 (44%) | 23 (46%) | |
No | 28 (56%) | 27 (54%) | |
History of drinking | 0.795 | ||
Yes | 8 (16%) | 10 (20%) | |
No | 42 (84%) | 40 (80%) | |
Family history | 0.795 | ||
Yes | 10 (20%) | 8 (16%) | |
No | 40 (80%) | 42 (84%) | |
T stage | 1 | ||
T1 | 1 (2%) | 1 (2%) | |
T2 | 29 (58%) | 29 (58%) | |
T3 | 14 (28%) | 14 (28%) | |
T4 | 6 (12%) | 6 (12%) | |
N stage | 1 | ||
N0 | 7 (14%) | 7 (14%) | |
N1 | 11 (22%) | 11 (22%) | |
N2 | 27 (54%) | 27 (54%) | |
N3 | 5 (10%) | 5 (10%) | |
Clinical stage | 1 | ||
II | 3 (6%) | 3 (6%) | |
III | 40 (80%) | 40 (80%) | |
IV | 7 (14%) | 7 (14%) | |
CCT | 50 (100%) | 50 (100%) | 1 |
Abbreviations: IMRT Intensity-modulated radiotherapy, ART adaptive radiotherapy, CCT concurrent chemotherapy